Edmond de Rothschild Holding’s VanEck Pharmaceutical ETF PPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-422
Closed -$33.2K 742
2023
Q2
$33.2K Hold
422
﹤0.01% 616
2023
Q1
$32.8K Sell
422
-3,818
-90% -$294K ﹤0.01% 627
2022
Q4
$330K Hold
4,240
0.01% 410
2022
Q3
$285K Sell
4,240
-2,073
-33% -$153K 0.01% 423
2022
Q2
$485K Buy
6,313
+3,850
+156% +$301K 0.01% 389
2022
Q1
$196K Buy
+2,463
New +$188K ﹤0.01% 500
2017
Q4
Sell
-200
Closed -$12K 825
2017
Q3
$12K Sell
200
-200
-50% -$11.4K ﹤0.01% 763
2017
Q2
$24K Hold
400
﹤0.01% 723
2017
Q1
$22K Hold
400
﹤0.01% 733
2016
Q4
$21K Hold
400
﹤0.01% 729
2016
Q3
$23K Buy
400
+200
+100% +$12K ﹤0.01% 746
2016
Q2
$12K Sell
200
-380
-66% -$22.1K ﹤0.01% 756
2016
Q1
$33K Buy
+580
New +$34.3K ﹤0.01% 676
2015
Q4
Sell
-21,770
Closed -$1.37M 868
2015
Q3
$1.37M Sell
21,770
-1,500
-6% -$105K 0.03% 249
2015
Q2
$1.65M Buy
+23,270
New +$1.68M 0.04% 237

Other funds holding PPH

Edmond de Rothschild Holding's PPH Position: Q3 2023 in Review

Edmond de Rothschild Holding sold out of VanEck Pharmaceutical ETF (PPH) in Q3 2023, closing a stake of 422 shares — an estimated $33.2K sold.

Edmond de Rothschild Holding first reported a position in PPH in Q2 2015 and held it in 15 quarters. The position peaked at $1.65M in Q2 2015. 102 funds tracked by Wall St. Rank hold PPH as of Q3 2023.

  • Edmond de Rothschild Holding reported no remaining VanEck Pharmaceutical ETF position as of Q3 2023 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 422 VanEck Pharmaceutical ETF shares in Q3 2023, an estimated $33.2K.
  • Edmond de Rothschild Holding first reported a position in VanEck Pharmaceutical ETF in Q2 2015 and held it in 15 quarters.
  • Edmond de Rothschild Holding's VanEck Pharmaceutical ETF position peaked at $1.65M in Q2 2015.
  • 102 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q3 2023.

Based on Edmond de Rothschild Holding's 13F filing for Q3 2023, filed 13 Nov 2023.